COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,006,250
-45.6%
36,498
-40.7%
0.01%
-46.7%
Q2 2023$1,851,035
-10.7%
61,578
+7.6%
0.02%
-16.7%
Q1 2023$2,073,733
+100371.6%
57,238
-1.1%
0.02%
+5.9%
Q4 2022$2,064
-99.9%
57,854
+18.7%
0.02%0.0%
Q3 2022$1,650,000
+17.2%
48,740
+0.1%
0.02%
+13.3%
Q2 2022$1,408,000
-5.0%
48,691
+6.2%
0.02%0.0%
Q1 2022$1,482,000
+26.5%
45,847
+14.1%
0.02%
+25.0%
Q4 2021$1,172,000
+9.0%
40,194
-0.3%
0.01%
-7.7%
Q3 2021$1,075,000
-14.2%
40,296
-1.0%
0.01%
-7.1%
Q2 2021$1,253,000
+17.2%
40,688
-0.3%
0.01%
+7.7%
Q1 2021$1,069,000
+4.1%
40,814
+0.0%
0.01%
-13.3%
Q4 2020$1,027,000
+20.5%
40,813
-0.1%
0.02%
-11.8%
Q3 2020$852,000
+35.7%
40,866
+54.5%
0.02%
+41.7%
Q2 2020$628,000
+32.2%
26,447
+0.2%
0.01%
+9.1%
Q1 2020$475,000
+12.6%
26,396
+48.4%
0.01%
+57.1%
Q4 2019$422,000
-13.7%
17,786
-0.0%
0.01%
-22.2%
Q3 2019$489,000
-17.7%
17,790
-0.8%
0.01%
-10.0%
Q2 2019$594,000
-5.6%
17,941
-0.1%
0.01%
-9.1%
Q1 2019$629,000
+5.7%
17,957
+0.2%
0.01%
-8.3%
Q4 2018$595,000
-5.3%
17,919
+43.8%
0.01%
+33.3%
Q3 2018$628,000
-4.3%
12,465
+13.8%
0.01%0.0%
Q2 2018$656,000
+196.8%
10,956
+127.3%
0.01%
+200.0%
Q1 2018$221,0004,8200.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders